| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |